SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-23-212400
Filing Date
2023-08-14
Accepted
2023-08-14 16:30:34
Documents
4
Group Members
SHENANDOAH ACQUISITION CORP

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d401100dsc13da.htm SC 13D/A 51360
2 EX-2.3 d401100dex23.htm EX-2.3 11075
3 GRAPHIC g401100dsp007.jpg GRAPHIC 3924
4 GRAPHIC g401100dsp007_a.jpg GRAPHIC 4482
  Complete submission text file 0001193125-23-212400.txt   76043
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filed by) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET STE 600 CAMBRIDGE MA 02142 617-336-7540
Sigilon Therapeutics, Inc. (Subject) CIK: 0001821323 (see all company filings)

IRS No.: 474005543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92195 | Film No.: 231170934
SIC: 2834 Pharmaceutical Preparations